Phyla: Funding, Investors & Team (Oct 2026)
Phyla is creating elective treatments for anti-infection agents. The focal point of most microbiome endeavors is to find valuable microorganisms to add to the microbiome, to fix sickness or keep up with wellbeing. Anyway others miss the mark on subtractive capability that can eliminate hurtful or illness causing microorganisms, that would permit the microbiome to rebalance and accomplish a stable sound state. Involving bacteriophages as an establishment, they are fostering a strong stage that permits us to specifically 'deduct' terrible microorganisms without hurting the great strains present locally. It's a piece like utilizing an expert marksman rather than an explosive to take out a trouble maker in a horde of individuals.
Phyla has raised $2.0M across 2 funding rounds on record, the most recent a Series A announced in Dec 2023.
Phyla Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Phyla Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Phyla raised $2.0M in a Seed announced in Jul 2022.
1.4 years later, a Series A was announced in Dec 2023 with no disclosed amount.
Phyla Founders and Leadership Team
Contact details for the Phyla team: 1 of 1 has an email address on file.
Start 14-day free trial →Phyla Funding Compared to Other Biotechnology Startups
Funded Startups Like Phyla in Biotechnology and San Francisco
Companies Similar to Phyla
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Phyla Funding FAQs
What does Phyla do?
Phyla is creating elective treatments for anti-infection agents. The focal point of most microbiome endeavors is to find valuable microorganisms to add to the microbiome, to fix sickness or keep up with wellbeing. Anyway others miss the mark on subtractive capability that can eliminate hurtful or illness causing microorganisms, that would permit the microbiome to rebalance and accomplish a stable sound state. Involving bacteriophages as an establishment, they are fostering a strong stage that permits us to specifically 'deduct' terrible microorganisms without hurting the great strains present locally. It's a piece like utilizing an expert marksman rather than an explosive to take out a trouble maker in a horde of individuals.
How much funding has Phyla raised?
Phyla has raised $2.0M across 2 rounds on record.
When did Phyla last raise funding?
Phyla's most recent funding round on record was announced in Dec 2023. The amount was not disclosed.
Who founded Phyla?
FundedIQ lists Yug Varma (Founder) at Phyla.
Where is Phyla headquartered?
Phyla is based in San Francisco, California, United States.
How many employees does Phyla have?
Phyla is in the 1-10 employee band.
About FundedIQ's Phyla Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phyla is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.